{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:47:57Z","timestamp":1783514877658,"version":"3.55.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203765"],"award-info":[{"award-number":["82203765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aims to evaluate the efficacy and safety of modified water vapor thermal therapy for large-volume benign prostatic hyperplasia (BPH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study enrolled 196 consecutive patients with prostate volume\u2009\u2265\u200980 mL who underwent modified water vapor thermal therapy at our institution between October 2023 and September 2024. All procedures were performed using the Rezum system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The procedures were successfully completed in all 196 patients with a median prostate volume of 96 mL. The IPSS decreased from a preoperative mean of 21.2\u2009\u00b1\u20093.9 to 11.7\u2009\u00b1\u20093.4 at 3 months, and further improving to 10.8\u2009\u00b1\u20093.8 at 1 year. Median prostate volume reduced from 96 mL to 60 mL. The QoL score improved from 4.3\u2009\u00b1\u20090.9 to 1.7\u2009\u00b1\u20091.1, and Qmax increased from 8.3\u2009\u00b1\u20092.3 mL\/s to 15.7\u2009\u00b1\u20093.5 mL\/s at 3 months. All observed improvements were statistically significant compared to baseline (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). The IIEF-5 score increased from 11.0\u2009\u00b1\u20093.6 to 14.1\u2009\u00b1\u20095.4 at 1 year, indicating a statistically significant improvement in erectile function (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05). The incidence of retrograde ejaculation was 3.1%. Only one patient (0.5%) required surgical retreatment during the follow-up period.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Modified water vapor thermal therapy demonstrates favorable efficacy and safety in the treatment of large-volume BPH. It is associated with significant symptom relief, functional improvement, and minimal complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-026-02050-3","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:34:47Z","timestamp":1770420887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modified water vapor thermal therapy for large-volume benign prostatic hyperplasia"],"prefix":"10.1186","volume":"26","author":[{"given":"Qun","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"2050_CR1","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","volume":"2","author":"B Chughtai","year":"2016","unstructured":"Chughtai B, Forde JC, Thomas DD, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016;2:16031.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2050_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00345-025-05948-z","volume":"43","author":"S Baug","year":"2025","unstructured":"Baug S, Beisland C, Moen CA, et al. Transurethral resection of the prostate in the extreme elderly (>\/= 85 years): treatment success, morbidity and survival. World J Urol. 2025;43(1):572.","journal-title":"World J Urol"},{"issue":"1","key":"2050_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00345-025-05699-x","volume":"43","author":"GM Pirola","year":"2025","unstructured":"Pirola GM, Castellani D, Naselli A, et al. Endoscopic enucleation of the prostate in men aged 80 years and older. Outcomes from a global, large, and multicenter series using different energy sources and techniques. World J Urol. 2025;43(1):344.","journal-title":"World J Urol"},{"issue":"1","key":"2050_CR4","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.1038\/s41598-017-06628-8","volume":"7","author":"SWH Lee","year":"2017","unstructured":"Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Sci Rep. 2017;7(1):7984.","journal-title":"Sci Rep"},{"issue":"1","key":"2050_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s12894-025-01970-w","volume":"25","author":"Q Jin","year":"2025","unstructured":"Jin Q, Zhang J, Wang G, et al. The endoscopic surgical monitoring system-guided impact factors exploring of blood loss and fluid absorption during plasmakinetic TURP: a prospective study in high-risk BPH patients. BMC Urol. 2025;25(1):287.","journal-title":"BMC Urol"},{"issue":"3","key":"2050_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/JU.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-Year outcomes of the multicenter randomized Sham-Controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021;206(3):715\u201324.","journal-title":"J Urol"},{"issue":"6","key":"2050_CR7","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","volume":"83","author":"JN Cornu","year":"2023","unstructured":"Cornu JN, Zantek P, Burtt G, et al. Minimally invasive treatments for benign prostatic obstruction: A systematic review and network Meta-analysis. Eur Urol. 2023;83(6):534\u201347.","journal-title":"Eur Urol"},{"issue":"3","key":"2050_CR8","first-page":"743","volume":"207","author":"Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia","year":"2022","unstructured":"Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia. AUA guideline PART II-Surgical evaluation and treatment. Erratum J Urol. 2022;207(3):743.","journal-title":"Erratum J Urol"},{"issue":"5","key":"2050_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.juro.2015.10.181","volume":"195","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy ablation: A Multicenter, Randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195(5):1529\u201338.","journal-title":"J Urol"},{"issue":"2","key":"2050_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"9","key":"2050_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/jama.2025.7045","volume":"334","author":"JT Wei","year":"2025","unstructured":"Wei JT, Dauw CA, Brodsky CN. Lower urinary tract symptoms in men: A review. JAMA. 2025;334(9):809\u201321.","journal-title":"JAMA"},{"issue":"6","key":"2050_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/CU9.0000000000000295","volume":"19","author":"R Balsamo","year":"2025","unstructured":"Balsamo R, Tammaro S, Fusco F, et al. Patients with frailty, benign prostatic hyperplasia and indwelling bladder catheter: what are the 1-year outcomes after Rezum therapy?. Curr Urol. 2025;19(6):396\u2013400.","journal-title":"Curr Urol"},{"key":"2050_CR13","doi-asserted-by":"crossref","unstructured":"Giulioni C, Talle M, Papaveri A, et al. The implementation of trifecta score to assess the quality of holmium laser enucleation of the prostate in elderly patients: an analysis of perioperative and functional outcomes and the impact of age. J Clin Med. 2025;14(10):3410.","DOI":"10.3390\/jcm14103410"},{"issue":"1","key":"2050_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ucl.2021.07.007","volume":"49","author":"D Elterman","year":"2022","unstructured":"Elterman D, Gao B, Lu S, et al. New technologies for treatment of benign prostatic hyperplasia. Urol Clin North Am. 2022;49(1):11\u201322.","journal-title":"Urol Clin North Am"},{"issue":"11","key":"2050_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1756287218793084","volume":"10","author":"J Westwood","year":"2018","unstructured":"Westwood J, Geraghty R, Jones P, et al. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol. 2018;10(11):327\u201333.","journal-title":"Ther Adv Urol"},{"issue":"6","key":"2050_CR16","first-page":"759","volume":"76","author":"R Balsamo","year":"2024","unstructured":"Balsamo R, Tammaro S, Trivellato M, et al. Water vapor thermal therapy (Rezum System) in patients with large prostates: results from a prospective comparative study. Minerva Urol Nephrol. 2024;76(6):759\u201367.","journal-title":"Minerva Urol Nephrol"},{"issue":"1","key":"2050_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12894-023-01237-2","volume":"23","author":"J Yang","year":"2023","unstructured":"Yang J, Wu W, Amier Y, et al. Efficacy and safety of water vapor thermal therapy in the treatment of benign prostate hyperplasia: a systematic review and single-arm Meta-analysis. BMC Urol. 2023;23(1):72.","journal-title":"BMC Urol"},{"issue":"1","key":"2050_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11934-020-01018-6","volume":"22","author":"SK Doppalapudi","year":"2021","unstructured":"Doppalapudi SK, Gupta N. What is new with Rezum water vapor thermal therapy for LUTS\/BPH?. Curr Urol Rep. 2021;22(1):4.","journal-title":"Curr Urol Rep"},{"key":"2050_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.urology.2023.10.036","volume":"184","author":"KT McVary","year":"2024","unstructured":"McVary KT, Miller LE, Bhattacharyya S, et al. Water vapor thermal therapy in men with prostate volume >\/=80\u00a0cm(3): A systematic review and Meta-Analysis. Urology. 2024;184:244\u201350.","journal-title":"Urology"},{"issue":"4","key":"2050_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/bju.15753","volume":"130","author":"D Elterman","year":"2022","unstructured":"Elterman D, Bhojani N, Vannabouathong C, et al. Rezum therapy for >\/=80-mL benign prostatic enlargement: a large, multicentre cohort study. BJU Int. 2022;130(4):522\u20137.","journal-title":"BJU Int"},{"key":"2050_CR21","first-page":"13","volume":"7","author":"CM Dixon","year":"2015","unstructured":"Dixon CM, Rijo Cedano E, Mynderse LA, et al. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015;7:13\u20138.","journal-title":"Res Rep Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02050-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02050-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02050-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:12:20Z","timestamp":1773223940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02050-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2050"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02050-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the Declaration of Helsinki. Ethical approval was obtained from the Ethical Committee of Nanjing Drum Tower Hospital, Medical School of Nanjing University. Written informed consent was obtained from all the patients involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients enrolled in this study provided written, informed consent for publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}